Connect with us

Cannabis News

Bipartisan Senators Push To Delay Federal Hemp THC Product Ban As Lawmakers Consider Regulatory Alternatives To Prohibition

Published

5 months ago

on

A bipartisan group of senators is pushing to give the hemp industry two more years before the federal ban on THC products takes effect, which activists hope will better position them to negotiate a broader compromise with lawmakers.

After President Donald Trump signed a spending bill last year with provisions that would have wiped out a prominent sector of the hemp economy, businesses and advocates quickly called for at least a delay in its implementation. Currently, the law will enter into force in November.

Now, Senators Amy Klobuchar (D-MN), Rand Paul (R-KY) and Jeff Merkley (D-OR) have introduced new legislation that would push that timeline back another two years, giving hemp interests more time to say the policy would significantly harm the industry, which was legalized in Trump’s first term under the 2018 Farm Bill.

The measureEntitled the Hemp Planting Provision Act, it simply states: “Section 781 of the Appropriations Act of 2026 of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (7 USC 1639o note; Public Law 119-37) is amended by striking “365 days” and inserting “365 years” in the subject matter before paragraph (1).

Rep. Jim Baird (R-IN) and bipartisan sponsor introduced similar legislation in the House to delay the hemp ban earlier this week.

House Oversight and Government Reform Committee Chairman James Comer (R-KY), who is sponsoring the proposal, appeared at a press conference on Thursday. farmers concerned about the impact of the federal hemp ban in their businesses.

what’s the point Four out of five marijuana users say they oppose the recriminalization of THC hemp products According to the spending bill Trump signed in November. However, it should be noted that this survey was conducted a few weeks before the cannabis rescheduling order and measures to protect access to full-spectrum CBD.

Trump signed an executive order last month directing the attorney general to change marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Part of that announcement also has implications for the upcoming hemp law. The president’s order also asked Congress consider updating the definition of hemp to ensure that full-spectrum CBD is available to patients.

Another redefinition of hemp would be part of a novel proposal allow Medicare recipients to access non-toxic CBD that would be covered under the federal health care plan.

To make this happen, the Centers for Medicare and Medicaid Services (CMS) will “enable a model that will allow certain CMS beneficiaries to benefit from receiving CBD at no cost on the basis of a physician’s recommendation,” a White House official announced in a briefing. Marihuana Moment first reported the leaked details ahead of the signing ceremony.

Trump appeared to support a more flexible CBD policy last summer shared a video calling for that exact reform while promoting the health benefits of cannabidiolespecially for the elderly.

Meanwhile, it would make way for a recently introduced bill in the Republican-led Congress stop implementing the hemp ban under established credit legislation.

Hemp companies and industry groups have warned about the potential ramifications of the ban, but despite states in support of cannabis rights and a recent social media post extolling the benefits of CBD, Trump signed the underlying spending measure into law without endorsing the hemp provisions.

GOP political operative Roger Stone recently said it was Trump effectively “forced” Republican lawmakers to sign the spending bill with language to ban hemp THC.

However, a White House spokesman said before signing the bill Trump was particularly supportive of the ban’s language.

The Democratic governor of Kentucky said that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—instead of being banned federally, as Congress has done—.

Additionally, a leading veterans organization is alerting Congressional leaders to the recently passed blanket ban on consumable hemp products. could inadvertently “close the door” on critical inquiry.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC by dry weight.

The new legislation specifies that, within a year of taking effect, the weight will be applied to total THC—including delta-8 and other isomers. Also, “as tetrahydrocannabinol (or any other marketed cannabinoid) with similar effects in humans or animals (as determined by the Secretary of Health and Human Services).”

The new definition of legal hemp will also prohibit “any hemp-derived cannabinoid intermediate product marketed or sold as an end product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or that are unable to produce it naturally.

Legal hemp products will be limited to a total of 0.4 milligrams of total THC or any other cannabinoid with similar effects per container.

Within 90 days of the bill’s passage, the Food and Drug Administration (FDA) and other agencies must “publish a list of all cannabinoids known to the FDA to be naturally produced by a Cannabis sativa L. plant, as reflected in the peer-reviewed literature,” which include “all tetrahydrocannabinol classes known” in natural plants and “known cannabinoids.” Cannabinoids that have or are marketed as having effects similar to cannabinoids of the tetrahydrocannabinol class.”

The language differs slightly from provisions in legislation advanced out of the House and Senate Appropriations panels, which would have banned products with “quantifiable” amounts of THC, to be determined by the HHS secretary and the agriculture secretary.

Read the full text of the Senate bill invoice below:

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

Village Farms International leads B.C. cannabis producers in global export push

Published

2 hours ago

on

June 27, 2026

By

Village Farms International, one of the world’s largest cannabis production facilities located in Delta, BC, increased its export volumes by more than 500 percent by the end of 2025, with international sales reaching US$37.9 million, or just over 20 percent of total cannabis revenue of US$188 million. The main export markets are Germany, Australia, the United Kingdom, New Zealand and Israel.

The company is also expanding, developing an additional 550,000 square feet of greenhouse space across the street from its main facility, designed to support both domestic and international cultivation. Orville Bovenschen, VFI’s global president of operations, points to the excise burden as a permanent strain on the domestic economy: “If you look at how much we paid in excise last year, it’s astronomical,” he says, although VFI declined to provide specific figures.

Walker Patton, one of the founders of the BC Cannabis Alliance, which represents about 50 licensed growers in the province, frames the domestic regulatory environment in stark terms: “With the rules that this industry was set up for, it’s like doing business right out of the gate.” Canada’s excise tax structure charges by weight instead of market price, meaning that since wholesale prices have fallen to roughly half of initial projections, effective tax rates for producers have risen.

© This is Holland

Sweetgrass Cannabis, a micro-farm located in the Kootenay region, now derives 60 to 70 percent of its sales from international markets after retreating from provinces such as Ontario and Alberta. Company CEO Gemma Hayes says: “Margins, as well as export opportunities, drove our decision.” Ontario’s wholesale markup of up to 25 per cent, layered with excise taxes, spurred what Hayes described as a “race to the bottom.”

Rubicon Organics, a Vancouver-based publicly traded company, entered international markets last year and recently opened a 47,500-square-foot facility in Hope in part to meet overseas demand. Speaking from the International Cannabis Conference in Berlin, Mathieu Aubin, director of marketing and new business, said: “Canada is very well positioned to access international markets for reliable and safe cannabis,” noting that reliability and product integrity are key to gaining access to the medical market.

Not all producers have equal access to these markets. Alex Rumi, founder of grower Good Buds out of Salt Spring Island, said established export markets are structured around an indoor pharmaceutical-style model that hurts sun-grown cannabis, and that Canada’s export system “works for big growers and doesn’t work for craft.” Julia Cameron, president of Cannabis Cultivators of BC and chair of communications and corporate affairs for the VFI, added that growers must secure permits for each shipment while navigating different rules across countries, creating a prohibitive barrier for small operators.

BC has more than 200 licensed growers and accounts for roughly a quarter of Canada’s legal cannabis production, but represents only 14 percent of national exports. Lana Popham, B.C.’s Minister of Agriculture and Food, points to the FIFA World Cup games in Vancouver as a near-term possibility: “It will be interesting to see how many people engage with what is a great product here in B.C.”

Continue Reading

Cannabis News

Congressman And Other Media Outlets Join Marijuana Moment’s Push For DEA To Livestream Rescheduling Hearing

Published

2 hours ago

on

June 27, 2026

By

The momentum of the Marijuana Moment request for direct public and media access to historic federal cannabis rescheduling hearings they are being joined by a member of Congress and other reporters starting next week.

Representative Steve Cohen (D-TN) sent a letter to the head of the Drug Enforcement Administration (DEA) on Friday, calling the ongoing marijuana rescheduling process “historic.”

“I am writing to request that the hearings be made available to the public in real time,” Cohen wrote to DEA Administrator Terrance Cole. “Live streaming technologies have become ubiquitous and a common way for Americans to interact with the government. In late 2024, in a similar effort, your agency authorized live streaming of proceedings ‘due to the public interest in this matter’ and continued your agency’s ‘commitment to procedural transparency.’

“I see no reason why that reason wouldn’t hold today, especially when it comes to such an important and impactful issue,” the congressman wrote. “I have long been an advocate for transparency in court proceedings and I believe this is a rare opportunity to inform the public about rulemaking and administrative litigation.”

Cohen’s letter follows a couple Marijuana Moment’s attorney presented the petitions to Cole and DEA Chief Administrative Law Judge Derek Julius. to request access to a live stream of the hearing on the proposal to move cannabis from Schedule I to Title III of the Controlled Substances Act (CSA) — which includes only opponents of the reform as participants.

Also on Friday, an attorney from Portfolio Media, Inc., which publishes Law360, sent Cole a letter saying it “agrees with Marijuana Moment’s request” for streaming access.

“This approach is consistent with DEA’s prior approach to this hearing and the compelling public interest in rescheduling marijuana under the CSA, a policy change with profound social, legal, and regulatory implications,” the letter states.

Requiring observers to attend in person “limits real-time information about a consequential policy development to the press and a small audience in attendance, and removes the ability of the press to report on that development,” he says. “Live streaming is a safe, continuous and fair way to ensure meaningful public access and advance the DEA’s stated commitment to transparency.”

Separately, an attorney representing the cannabis publication Cultivated Media and also on behalf of New York Times reporter Ashley Southall sent a letter to the DEA administrator saying they “want the ability to monitor the proceedings in real time, to provide readers with reports on the progress and perspective of testimony and evidence during the hearing.”

“Cultivated Media, Ashley Southall and Marijuana Moment and all the other media because of this access to the live stream can simultaneously report on issues of important public concern related to a historic hearing,” he said.

The DEA announced Thursday that it would make the transcript available at the end of the multi-day hearing, but Marijuana Moment attorney Joseph A. Bondy wrote in his letter Thursday that it would not help the public follow the proceedings in real time on a daily basis.

“The final transcript is useful, but not a substitute for access to a live broadcast. A live broadcast allows the public and the press to observe the hearing as it unfolds without contesting admissions, filling the courtroom, or disrupting the proceedings,” the letter to Cole says. “After reviewing, correcting and releasing the transcript weeks after the testimony, the opportunity for real-time observation, timely reporting and public information response has passed.”

“For a large public audience seeking serious coverage of federal cannabis policy, Marihuana Moment is an important channel through which the public can understand these proceedings.”

“To the extent that the DEA now believes that live streaming is inappropriate, despite the DEA’s prior directive in this rulemaking, Marijuana Moment respectfully requests a written explanation identifying the specific basis for that conclusion, including why the public interest and transparency that previously warranted live streaming are being overridden here,” Bondy wrote.

—
Marijuana Moment’s journalism is made possible by readers like you, who value this work enough to support us monthly pledges on Patreon. If you rely on our reports to stay informed of important developments in cannabis, please help us do this becoming a permanent subscriber today.

Backing us at the $25/month level, you’ll have access to our Bill Tracker so you don’t miss any important marijuana legislation in your state.
—

Separately, cannabis advocates sent a letter Thursday to Julius, the DEA judge, saying he would not consider submissions from outside parties, also requesting access to the live stream.

“Many of the patients most interested in this procedure cannot travel to Arlington, Virginia. Many are disabled, immunocompromised, elderly, financially limited, or managing serious medical conditions,” states the letter from Americans for Safe Access, Veterans Initiative-22, US Pain Foundation, Realm of Caring, Montel Williams and others.

“Patients and advocates who can travel will also be unable to physically wait in line for an uncertain chance of admission, only to be turned away when limited seats are filled,” they wrote. “So the audience may technically be open to the public, but virtually inaccessible to most.”

Meanwhile, the DEA said in a new filing that its witness list for the hearing includes a doctor. Testify on “How Medical Marijuana Provides Medical Benefit to Pain Patients.”

Separately, the opponents who are participating in the trial have presented their declarations this week anticipate the anti-marijuana arguments they intend to make during the procedure.

The hearing it will start on June 29 and end before July 15.

Acting Attorney General Todd Blanche in April He issued an order that immediately reclassified the state’s licensed medical cannabisas well as marijuana products approved by the Food and Drug Administration (FDA) under Schedule I through Schedule III of the Controlled Substances Act (CSA).

According to a separate order signed by the acting attorney general, the upcoming hearing will include Class III marijuana.

Preliminary hearing process on the marijuana redistricting process initiated by the Biden administration It was halted last year amid allegations of improper communications and witness selection.

the current The marijuana redistricting process is being challenged in several ways which have been upheld by a federal Court of Appeals. those pieces of State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

Meanwhile, the reorganization of state-licensed medical cannabis is already having a major impact.

The Congressional Research Service published a report on the current rescheduling of cannabis Certified patients with medical marijuana from state licensed dispensaries are now eligible for Class III. “The order appears to allow end users to use marijuana medically without a CSA prescription,” he says.

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has published a Draft update to a gun purchase form to recognize the legal status of medical marijuana in the reprogramming. The revised section of the question states that only the “recreational use or possession of marijuana” is federally prohibited, omitting the prior form’s mention of medical cannabis.

The US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after reprogramming. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

Even the DEA, which has long opposed cannabis legalization and accused the Biden administration of stalling the initiative in the reorganization process, has done so. It launched a registration process for legal marijuana businesses in the state to take advantage of the federal benefits that come with the reform.

The Department of Transport, on the other hand, issued guidelines stating this use Legal medical cannabis in the state is still no excuse for truck drivers to test positive for drugspilots and other safety-sensitive personnel.

A congressional committee recently Federal officials voted to block further steps to reschedule cannabis.

read it the letters About DEA admin access to live streaming:

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

New access solution for cannabis facilities designed to address limitations of traditional gates

Published

1 day ago

on

June 26, 2026

By











SpaceGuard Products, a North American manufacturer of wire mesh security solutions and security protection systems, has released the BeastWire® Tunnel Door. This access solution is designed to overcome the limitations of traditional balanced doors and is aimed at cannabis cultivation, processing, packaging and distribution environments. The BeastWire Tunnel Door is designed for installations that require vertical clearance, reliable movement and floor space efficiency.

The BeastWire Tunnel Door provides top clearance with no tracks in the operating path of the door. It is suitable for spaces where overhead paths are not feasible, such as facilities that use high-mast forklifts, oversized pallet loads or specialized material handling equipment. Tall equipment can pass through the opening unhindered, allowing for continuous workflow and flexibility in equipment movement.

© SpaceGuard Products

The door uses a track system designed to create consistent movement. This addresses issues such as stuttering, binding, and misalignment that can occur with conventional sliding or counterbalanced designs. The track controls the path of the door so that the locking mechanism aligns with each cycle, allowing operators to close the door with relatively low force.

Unlike lower track systems that require a soil trench, the BeastWire Tunnel Door mounts above ground. This avoids cutting the installation slab, simplifies installation and reduces maintenance requirements. The system can be installed as a retrofit or in new construction, without changing the floor.

© SpaceGuard Products

The door frame and retractable design reduces the need for side supports and additional space on the side of the door. This results in a smaller footprint and more usable surface area. The gate has the same construction approach as other BeastWire systems.

The BeastWire Tunnel Door is a high-access door designed for strength and ease of use in cannabis industry facilities.

For more information:
SpaceGuard products
Email: (email protected)
spaceguardproducts.com/










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media